Soleno Therapeutics Inc (SLNO)
Operating Income Growth
169.44%
Quarterly · Period ending:
SLNO Operating Income Growth
Year-over-year change vs the same period a year earlier
Latest reported169.44%period ending
Latest reported169.44%period ending
SLNO Quarterly Operating Income YoY % (-136.39% → 169.44%)
Year-over-year change
High-resolution chart · PNG
SLNO operating income growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Income Growth |
|---|---|
| 169.4358% | |
| 168.3927% | |
| 127.5582% | |
| 71.9125% | |
| -94.8584% | |
| -324.9892% | |
| -672.6064% | |
| -169.4074% | |
| -177.1874% | |
| -147.9501% | |
| -66.5116% | |
| -27.2017% | |
| -46.7002% | |
| -86.9377% | |
| 24.7526% | |
| 38.8453% | |
| -163.0516% | |
| 62.2848% | |
| -5.4601% | |
| 0.9649% | |
| -1.3575% | |
| -15.6541% | |
| -28.6978% | |
| -99.0574% | |
| 286.4604% | |
| -94.6252% | |
| -57.4265% | |
| -64.7524% | |
| -43.2518% | |
| 32.0103% | |
| -44.2172% | |
| -6.324% | |
| -57.2398% | |
| -75.8834% | |
| 8.5685% | |
| 6.9565% | |
| 48.1586% | |
| 15.702% | |
| 7.6029% | |
| -13.3377% | |
| -75.7214% | |
| -89.9925% | |
| -140.5896% | |
| -132.8998% | |
| -254.4255% | |
| -229.7222% | |
| -33.2326% | |
| -11.135% | |
| -136.3853% |